University　of　Occupational　and　Environmental　Health,　Japan · Faculty of Medicine / Graduate School of Medicine

Research keywordsmedicine・Tremelimumab・Internal

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Long-chain fatty acyl CoA synthetase 4 expression in pancreatic cancer: a marker for malignant lesions and prognostic indicator for recurrence2025 · Diagnostic Pathology 20(1) 2025年5月10日査読有り
• Association of Metabolic‐Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study2025 · Hepatology Research 55(12) 1642-1651 2025年8月21日査読有り
• Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab2025 · Cancers 17(8) 1274-1274 2025年4月9日査読有り筆頭著者
• Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Induces Hepatic Iron Overload in a Susceptible Patient2025 · Internal Medicine 64(9) 1334-1337 2025年5月1日査読有り

• 糖尿病病態生理モデルに基づくうつ病の病態解明と治療法開発に関する研究2018
• 細胞ストレス防御機構の阻害を介したソラフェニブの抗腫瘍効果2016

• Official profile